Orthocell is a small cap, 100 million company, it’s perfectly...

Orthocell is a small cap, 100 million company, it’s perfectly normal for the share price to raise on announcement day and get sold back down within a few hours, days, weeks, very frustrating to watch but we are a small cap with big dreams

I first bought into this company close to seven year, when the share price was on the increase and topped out @99 cents, back when Port Phillip Publishing first recommended Orthocell. PPP, like many other trading companies, want results for their subscribers, and Orthocell was, as usual dragging the chain, and letting the team down

There has been three big Capital Raises in that time, where institutional investors have been let down because of blown out time frames, shitty management skills and a share price that gets sold back down faster than it goes up. Mud sticks when you are trying to profit for your investors. That twenty million in the bank from CRs helped finish trials, get approvals, set up a manufacturer plant in the US to ready the company for partnership / commercialisation

A partnership will happen, just depends on who and when. Our share price at the moment is of little concern once our first partnership is formed, my guess Striate+ will be first in the US as we are FDA approved, locked and loaded ready for manufacturing